Här finner du korta presentationer av de bolag som LSI Beta investerat i.
Nyheter kring bolagen finner du under Aktuellt.
Iscaffpharma’s mission is to establish the scaffold technology as gold standard for cancer drug development and develop own successful treatments for aggressive cancer. We use a new technology with human and 3D printed scaffolds that mimic true human environment resulting in increased success rate in clinical development of cancer drugs.
Suturion is bringing a new gold standard to the market for abdominal wall closure and an easier and improved way of working. Suture-TOOL has been developed for swift and standardized abdominal wall closure. The technology is developed from a clinical need and experience and have research-based evidence with proof of concept in various pre-clinical models.